arrowTo report an adverse event

arrowFor any other medical emergency or R&D questions

Search

Choose site

Rottapharm | Madaus
is now part of Meda AB

Investor Relations

Since 31st July 2014 Rottapharm joined MEDA group, becoming a leading European Specialty Pharma company.

Click here to enter the Meda Investor Relations area.

Investor Relations contacts:

Email: ir@meda.se

Paula Treutiger
Vice President Corporate Communications & Sustainability
Meda AB
Direct +46 8 630 2082
E-mail: paula.treutiger@meda.se

 

 

 

Top